[go: up one dir, main page]

DK1378267T3 - Anvendelse af flumazenil til fremstilling af et medikament til behandling af kokainafhængighed - Google Patents

Anvendelse af flumazenil til fremstilling af et medikament til behandling af kokainafhængighed

Info

Publication number
DK1378267T3
DK1378267T3 DK02711879T DK02711879T DK1378267T3 DK 1378267 T3 DK1378267 T3 DK 1378267T3 DK 02711879 T DK02711879 T DK 02711879T DK 02711879 T DK02711879 T DK 02711879T DK 1378267 T3 DK1378267 T3 DK 1378267T3
Authority
DK
Denmark
Prior art keywords
flumazenil
treatment
drug
manufacture
cocaine addiction
Prior art date
Application number
DK02711879T
Other languages
English (en)
Inventor
Ibanez Juan Jose Legarda
Original Assignee
Hythiam Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hythiam Inc filed Critical Hythiam Inc
Application granted granted Critical
Publication of DK1378267T3 publication Critical patent/DK1378267T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DK02711879T 2001-02-15 2002-02-08 Anvendelse af flumazenil til fremstilling af et medikament til behandling af kokainafhængighed DK1378267T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100342 2001-02-15
PCT/ES2002/000061 WO2002064213A1 (es) 2001-02-15 2002-02-08 Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la dependencia de cocaina

Publications (1)

Publication Number Publication Date
DK1378267T3 true DK1378267T3 (da) 2007-10-08

Family

ID=8496743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02711879T DK1378267T3 (da) 2001-02-15 2002-02-08 Anvendelse af flumazenil til fremstilling af et medikament til behandling af kokainafhængighed

Country Status (21)

Country Link
US (2) US7186711B2 (da)
EP (1) EP1378267B1 (da)
JP (2) JP4272885B2 (da)
KR (1) KR100712571B1 (da)
CN (1) CN1327843C (da)
AT (1) ATE363923T1 (da)
AU (1) AU2002231811B2 (da)
BR (1) BR0207866A (da)
CA (1) CA2436511C (da)
CY (1) CY1106845T1 (da)
DE (1) DE60220512T2 (da)
DK (1) DK1378267T3 (da)
ES (1) ES2287255T3 (da)
HK (1) HK1061817A1 (da)
IL (1) IL157144A0 (da)
MX (1) MXPA03007281A (da)
NZ (1) NZ528164A (da)
PT (1) PT1378267E (da)
RU (1) RU2322985C2 (da)
UA (1) UA79586C2 (da)
WO (1) WO2002064213A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192271A1 (en) * 2003-07-15 2005-09-01 Hythiam, Inc. Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
JP4272885B2 (ja) 2001-02-15 2009-06-03 ハイチアム,インコーポレイテッド コカイン依存症治療用薬剤
WO2006110642A2 (en) 2005-04-07 2006-10-19 Hythiam, Inc. Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
US7855196B2 (en) 2005-08-22 2010-12-21 Pierre Mainville Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist
ES2289935B1 (es) * 2006-07-14 2008-12-16 Juan Jose Legarda Ibañez Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la patologia depresiva.
WO2009027564A1 (es) * 2007-08-08 2009-03-05 Legarda Ibanez Juan Jose Uso y métodos de uso de un antagonista del receptor (5-ht3) de la serotonina3 y un modulador selectivo de los canales de cloruro para el tratamiento de la adicción a o la dependencia de fármacos/drogas o trastornos del sistema nervioso central
US9396280B2 (en) * 2008-06-23 2016-07-19 Microsoft Technology Licensing, Llc Command driven web site browsing
AU2012221704B2 (en) 2011-02-23 2013-12-05 Coeruleus Ltd. Flumazenil complexes, compositions comprising same and uses thereof
WO2014113617A1 (en) 2013-01-21 2014-07-24 Innovative Finishes LLC Refurbished component, electronic device including the same, and method of refurbishing a component of an electronic device
US20160256472A1 (en) * 2013-10-14 2016-09-08 Palmaya Pty Ltd Compositions and methods of administering same
CN107115359A (zh) * 2016-02-24 2017-09-01 郑恩哲 阻断海洛因或吗啡毒品中毒路径的点滴处方及其应用
EP3661500A1 (en) 2017-07-31 2020-06-10 Novartis AG Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028611A (en) * 1989-06-29 1991-07-02 The Regents Of The University Of Minnesota Treatment for cocaine use
US5229120A (en) * 1992-02-05 1993-07-20 Devincent James F Treatment for cocaine abuse
GB9420010D0 (en) 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
WO2000030648A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
EP1125579A3 (en) * 2000-01-18 2003-01-02 Pfizer Products Inc. Uses of agrp-melanocortin receptor binding modulating compounds
JP4272885B2 (ja) 2001-02-15 2009-06-03 ハイチアム,インコーポレイテッド コカイン依存症治療用薬剤
US6740677B2 (en) 2002-08-19 2004-05-25 Hong Xue Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids

Also Published As

Publication number Publication date
JP4272885B2 (ja) 2009-06-03
US20060122219A1 (en) 2006-06-08
ES2287255T3 (es) 2007-12-16
KR100712571B1 (ko) 2007-05-02
ATE363923T1 (de) 2007-06-15
IL157144A0 (en) 2004-02-08
NZ528164A (en) 2006-03-31
BR0207866A (pt) 2004-03-23
PT1378267E (pt) 2007-09-11
MXPA03007281A (es) 2005-01-25
CN1491125A (zh) 2004-04-21
KR20040010592A (ko) 2004-01-31
UA79586C2 (en) 2007-07-10
US7186711B2 (en) 2007-03-06
WO2002064213A1 (es) 2002-08-22
JP2004521904A (ja) 2004-07-22
RU2003127718A (ru) 2005-01-27
EP1378267B1 (en) 2007-06-06
CA2436511A1 (en) 2002-08-22
AU2002231811B2 (en) 2006-02-16
CN1327843C (zh) 2007-07-25
HK1061817A1 (en) 2004-10-08
JP2008201799A (ja) 2008-09-04
CY1106845T1 (el) 2012-05-23
DE60220512D1 (de) 2007-07-19
US20070142364A1 (en) 2007-06-21
EP1378267A1 (en) 2004-01-07
DE60220512T2 (de) 2008-02-07
CA2436511C (en) 2009-08-04
RU2322985C2 (ru) 2008-04-27

Similar Documents

Publication Publication Date Title
CY1107500T1 (el) Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
SE0104388D0 (sv) New formulation and use and manufacture thereof
DE60126923D1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
CY1106845T1 (el) Χρηση της φλουμαζενιλης για την παρασκευη ενος φαρμακου για την αγωγη της εξαρτησεως απο την κοκαϊνη
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60115418D1 (de) Mikroinfusionsvorrichtung zur verabreichung von medikamenten
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
EE05301B1 (et) Meetod epotilooni analooge sisaldavate ravimvormide valmistamiseks ning nende kasutamine ravimi valmistamiseks
DE60237302D1 (de) Stent zur abgabe einer therapeutischen substanz oder anderer mittel
CY2009002I2 (el) Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
BR0208382A (pt) Forma de dosagem oral contendo nicotina
EP1781256A4 (en) PHOSPHOLIPIDE-GEL COMPOSITIONS FOR DRUG DISPOSAL AND METHOD FOR THE TREATMENT OF ILLNESSES THEREWITH
ATE302774T1 (de) Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DK1246625T3 (da) Anvendelser og sammensætninger af nitratestere til tilvejebringelse af sedering
EE200300363A (et) N-(püridinüül)-1H-indool-1-amiinühendite kasutamine ravimi valmistamiseks, mis on ette nähtud müeliinikaotusega seotud haiguste ja seisundite ravimiseks
NO20025394D0 (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
DE60121047D1 (de) Pharmazeutische zusammensetzung zur behandlung von phimose mit einem topischen corticosteroid
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
DK1572622T3 (da) Anvendelse af levalbuterol-L-tartrat ved fremstilling af en doseringsinhalator
HUP0300876A3 (en) Use of diclofenac for the manufacture of medicament for the topical treatment of burns
BRPI0413908A (pt) formulação farmacêutica neuroterapêutica em forma de dosagem oral, composto, e, método de tratamento de um distúrbio comportamental ou um distúrbio cognitivo